This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Insider Trading Alert - WETF, CI And PANW Traded By Insiders

Cigna (CI) - FREE Research Report

Cordani David who is President & CEO at Cigna sold 100,800 shares at $79.21 on March 11, 2014. Following this transaction, the President & CEO owned 214,208 shares meaning that the stake was reduced by 32% with the 100,800-share transaction.

Manders Matthew G who is Pres. Regional & Operations at Cigna sold 18,136 shares at $79.34 on March 11, 2014. Following this transaction, the Pres. Regional & Operations owned 48,708 shares meaning that the stake was reduced by 27.13% with the 18,136-share transaction.

Sadler Jason D who is Pres. Global Individual HL&A at Cigna sold 9,911 shares at $78.92 on March 11, 2014. Following this transaction, the Pres. Global Individual HL&A owned 19,387 shares meaning that the stake was reduced by 33.83% with the 9,911-share transaction.

The shares most recently traded at $79.67, up $0.75, or 0.95% since the insider transaction. Historical insider transactions for Cigna go as follows:

  • 4-Week # shares sold: 514
  • 12-Week # shares sold: 514
  • 24-Week # shares sold: 6,695

The average volume for Cigna has been 1.8 million shares per day over the past 30 days. Cigna has a market cap of $21.6 billion and is part of the health care sector and health services industry. Shares are down 9.61% year-to-date as of the close of trading on Friday.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The stock currently has a dividend yield of 0.05%. The company has a P/E ratio of 15.3. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CI - FREE

TheStreet Quant Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cigna Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Submit an article to us!
DOW 17,131.51 -0.46 -0.00%
S&P 500 1,997.67 -1.31 -0.07%
NASDAQ 4,551.6710 -1.0880 -0.02%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs